Abstract 3051: Targeting cdk12/13 re-sensitizes trastuzumab resistant her2+ breast cancers

Authors: Francesca Vena, Max Aceti, Simon Bayle, Victor Quereda, Andrii Monastyrskyi, William Roush, Derek Duckett

Published: 2019-08-07

DOI: 10.1158/1538-7445.am2019-3051

Source: Full article